Nanoscale Coordination Polymers (NCP) for Platinum â€“Resistant Ovarian Cancer
University of Chicago, IL, United States
NCP drug delivery platforms have the potential to overcome many drawbacks of existing drug delivery systems such as low drug loading. The NCP offers controlled drug cargo release, modular surface structures contribute to NCP targeting, lower drug dosage, and siRNA for added gene therapy in one formulation.
Primary Application Area: Biotech & Biological Sciences
Technology Development Status: Prototype
Technology Readiness Level: TRL 3
FIGURES OF MERIT
Value Proposition: Nanoscale Coordination Polymers (NCP) drug delivery platforms are significantly more effective than small molecule drugs in solid tumors, even with 16.7% to 40% of the dose of free drugs. The new formulation also has a lower toxicity profile.
Organization Type: Academic/Gov Lab
Showcase Booth #: 637
GOVT/EXTERNAL FUNDING SOURCES
Government Funding/Support to Date:
Primary Sources of Funding: Federal Grant
Looking for: Both Funding and Development Partners